Related Experiment Video
Updated: May 25, 2026
08:57
Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
Published on: May 17, 2024
Neoplasms associated with germline and somatic NF1 gene mutations
Sachin Patil1, Ronald S Chamberlain
1Department of Surgery, Saint Barnabas Medical Center, 94 Old Short Hills Road, Livingston, New Jersey 07039, USA.
The Oncologist
|January 14, 2012
Summary
Malignancies in Neurofibromatosis 1 (NF1) patients occur earlier and have poorer outcomes. Early detection and standardized management are crucial for improving survival in NF1-associated tumors.
Area of Science:
- Oncology
- Genetics
- Pediatrics
Background:
- Neurofibromatosis 1 (NF1) is an autosomal dominant genetic syndrome caused by NF1 gene mutations, leading to decreased neurofibromin, a key regulator of cell proliferation.
- While NF1 predisposes individuals to malignancies, additional genetic alterations are required for tumor development, and their nature is not fully understood.
- Somatic NF1 gene alterations are linked to sporadic cancers like colon adenocarcinoma, myelodysplastic syndrome, and anaplastic astrocytoma.
Purpose of the Study:
- To review and analyze existing literature on malignancies associated with Neurofibromatosis 1 (NF1).
- To compare the characteristics, presentation, and outcomes of NF1-associated malignancies with their sporadic counterparts.
- To identify challenges in managing NF1-related cancers and propose future research directions.
Main Methods:
- A comprehensive literature search was conducted using PubMed, encompassing English and non-English articles.
- Keywords included "malignancies associated with NF1", "tumors associated with NF1", and "NF1 and malignancies".
- Published data were analyzed for age of onset, presentation, diagnostic and therapeutic modalities, and patient outcomes, comparing NF1 cases with sporadic malignancies.
Main Results:
- Malignancies in NF1 patients generally manifest at an earlier age compared to the general population.
- Except for optic pathway gliomas, NF1-associated malignancies often have a poorer prognosis than sporadic tumors.
- Malignancies represent the leading cause of mortality in NF1 patients, significantly reducing life expectancy by 10–15 years.
Conclusions:
- The absence of effective screening tests and nonspecific clinical signs contribute to adverse outcomes for malignancies in NF1.
- Challenges in comparing treatment outcomes stem from small, heterogeneous patient groups and inconsistent reporting.
- An international consensus is needed to establish best practices for screening, diagnosis, management, and follow-up of NF1-related malignancies.
More Related Videos
Related Concept Videos
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:12Loss of Tumor Suppressor Gene Functions
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...